28/11/2016 : Theradiag wins the Ile de France (Paris) Chamber of Commerce and Industry award for its export activities

Croissy-Beaubourg and Montpellier, November 28, 2016 – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, has announced that it has won the “Exporter” award from the Ile de France Chamber…

Continue Reading28/11/2016 : Theradiag wins the Ile de France (Paris) Chamber of Commerce and Industry award for its export activities

10/10/2016 : Substantial potential reduction in treatment costs thanks to biotherapy monitoring

Croissy-Beaubourg and Montpellier, October 10, 2016 – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, today announces that a systematic review of the pharmaco-economic studies published in the Journal…

Continue Reading10/10/2016 : Substantial potential reduction in treatment costs thanks to biotherapy monitoring